{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T04:01:45Z","timestamp":1791864105671,"version":"4.3.4"},"reference-count":30,"publisher":"Massachusetts Medical Society","issue":"5","license":[{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.nejmgroup.org\/legal\/terms-of-use.htm"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000538","name":"Breast Cancer Trials","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000538","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Alliance Foundation Trials"},{"DOI":"10.13039\/501100024069","name":"German Breast Group","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024069","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fondazione Michelangelo"},{"name":"SOLTI"},{"name":"PrECOG"},{"DOI":"10.13039\/501100021564","name":"Unicancer","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100021564","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N Engl J Med"],"published-print":{"date-parts":[[2026,1,29]]},"DOI":"10.1056\/nejmoa2511218","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T22:00:21Z","timestamp":1769637621000},"page":"451-462","source":"Crossref","is-referenced-by-count":48,"title":["Palbociclib for Hormone-Receptor\u2013Positive, HER2-Positive Advanced Breast Cancer"],"prefix":"10.1056","volume":"394","author":[{"given":"Otto","family":"Metzger","sequence":"first","affiliation":[{"name":"Dana\u2013Farber Cancer Institute, Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumithra","family":"Mandrekar","sequence":"additional","affiliation":[{"name":"Alliance Foundation Trials Statistics and Data Center, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shom","family":"Goel","sequence":"additional","affiliation":[{"name":"Peter MacCallum Cancer Centre, Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Gligorov","sequence":"additional","affiliation":[{"name":"Institut Universitaire de Canc\u00e9rologie, Assistance Publique\u2013H\u00f4pitaux de Paris, Sorbonne Universit\u00e9, Tenon Hospital and INSERM Unit\u00e9 938, Paris"},{"name":"Unicancer Breast Group, Paris"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elgene","family":"Lim","sequence":"additional","affiliation":[{"name":"Garvan Institute of Medical Research, Sydney"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Ciruelos","sequence":"additional","affiliation":[{"name":"Hospital 12 de Octubre, Madrid"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibylle","family":"Loibl","sequence":"additional","affiliation":[{"name":"German Breast Group, Neu-Isenburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis","family":"Dockter","sequence":"additional","affiliation":[{"name":"Alliance Foundation Trials Statistics and Data Center, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Gonz\u00e0lez Farr\u00e9","sequence":"additional","affiliation":[{"name":"Institut Oncol\u00f2gic Dr. Rosell, Hospital General de Catalunya i Quir\u00f3n Dexeus, Barcelona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prudence A.","family":"Francis","sequence":"additional","affiliation":[{"name":"Peter MacCallum Cancer Centre, Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filipa","family":"Lynce","sequence":"additional","affiliation":[{"name":"Dana\u2013Farber Cancer Institute, Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Lanzillotti","sequence":"additional","affiliation":[{"name":"Alliance Foundation Trials, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carter","family":"DuFrane","sequence":"additional","affiliation":[{"name":"Alliance Foundation Trials, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Wall","sequence":"additional","affiliation":[{"name":"Alliance Foundation Trials Statistics and Data Center, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie","family":"Strand","sequence":"additional","affiliation":[{"name":"Alliance Foundation Trials Statistics and Data Center, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Krop","sequence":"additional","affiliation":[{"name":"Yale School of Medicine, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Vaz-Luis","sequence":"additional","affiliation":[{"name":"Cancer Survivorship, INSERM Unit\u00e9 981, Institut Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debu","family":"Tripathy","sequence":"additional","affiliation":[{"name":"University of Texas M.D. Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherene","family":"Loi","sequence":"additional","affiliation":[{"name":"Peter MacCallum Cancer Centre, Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleix","family":"Prat","sequence":"additional","affiliation":[{"name":"Clinic Barcelona Comprehensive Cancer Center, Barcelona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Goetz","sequence":"additional","affiliation":[{"name":"Alliance Foundation Trials Statistics and Data Center, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Escriv\u00e1-de-Roman\u00ed","sequence":"additional","affiliation":[{"name":"Vall d\u2019Hebron Institut of Oncology, Hospital Vall d\u2019Hebron, Barcelona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Porter","sequence":"additional","affiliation":[{"name":"Auckland District Health Board, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Spoenlein","sequence":"additional","affiliation":[{"name":"Kliniken Essen-Mitte, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel G.","family":"Stover","sequence":"additional","affiliation":[{"name":"Ohio State University Comprehensive Cancer Center\u2013James Cancer Hospital and Solove Research Institute, Columbus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagar","family":"Sardesai","sequence":"additional","affiliation":[{"name":"Ohio State University Comprehensive Cancer Center\u2013James Cancer Hospital and Solove Research Institute, Columbus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Heudel","sequence":"additional","affiliation":[{"name":"Centre L\u00e9on B\u00e9rard, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Koehler","sequence":"additional","affiliation":[{"name":"Pfizer, Collegeville, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Huang Bartlett","sequence":"additional","affiliation":[{"name":"Pfizer, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariadna","family":"Holynskyj","sequence":"additional","affiliation":[{"name":"Pfizer, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashanth","family":"Gopalakrishna","sequence":"additional","affiliation":[{"name":"Pfizer, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Gauthier","sequence":"additional","affiliation":[{"name":"Pfizer, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzette","family":"Delaloge","sequence":"additional","affiliation":[{"name":"Cancer Survivorship, INSERM Unit\u00e9 981, Institut Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Miller","sequence":"additional","affiliation":[{"name":"Indiana University School of Medicine, Indianapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric P.","family":"Winer","sequence":"additional","affiliation":[{"name":"Yale School of Medicine, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Gianni","sequence":"additional","affiliation":[{"name":"Fondazione Michelangelo Onlus, Milan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann H.","family":"Partridge","sequence":"additional","affiliation":[{"name":"Dana\u2013Farber Cancer Institute, Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"DeMichele","sequence":"additional","affiliation":[{"name":"University of Pennsylvania School of Medicine, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2388-4649","authenticated-orcid":false,"given":"Lisa A.","family":"Carey","sequence":"additional","affiliation":[{"name":"Lineberger Comprehensive Cancer Center, UNC Health, Chapel Hill, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"150","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.3798106"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1113216"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1413513"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dju055"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-16-0520"},{"key":"e_1_3_4_7_2","unstructured":"National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology (NCCN guidelines) for breast cancer version 5.2025."},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.09.019"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.0948"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2024.103756"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-2728"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.2002-220620"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-023-00533-2"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/35082500"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2005.12.012"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2419"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2012.09.015"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2016.02.006"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-21-3185"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30001-9"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-0844"},{"key":"e_1_3_4_22_2","doi-asserted-by":"crossref","unstructured":"Malorni L Tyekucheva S Zamagni C et al. Palbociclib plus letrozole versus weekly paclitaxel both in combination w\/ trastuzumab plus pertuzumab as neoadjuvant treatment for patients w\/ HR+\/HER2+ early breast cancer: primary results from the randomized phase II TOUCH trial (IBCSG 55-17). Clin Cancer Res 2025;31:Suppl 12:RF1-02-RF1-02.","DOI":"10.1158\/1557-3265.SABCS24-RF1-02"},{"key":"e_1_3_4_23_2","doi-asserted-by":"crossref","unstructured":"Patel R Cascetta K Klein P et al. A multicenter phase I\/II trial of anastrozole palbociclib trastuzumab and pertuzumab in hormone receptor (HR)-positive HER2-positive metastatic breast cancer (ASPIRE). Cancer Res 2024;84:Suppl 9:RF02-01-RF02-01.","DOI":"10.1158\/1538-7445.SABCS23-RF02-01"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-23-1209"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22885"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2018-0902-SA"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-22-1092"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-022-00456-3"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1607303"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djy109"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.06.024"}],"container-title":["New England Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMoa2511218","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T14:20:34Z","timestamp":1774621234000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nejm.org\/doi\/10.1056\/NEJMoa2511218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,1,29]]}},"alternative-id":["10.1056\/NEJMoa2511218"],"URL":"https:\/\/doi.org\/10.1056\/nejmoa2511218","relation":{},"ISSN":["0028-4793","1533-4406"],"issn-type":[{"value":"0028-4793","type":"print"},{"value":"1533-4406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,29]]}}}